268 related articles for article (PubMed ID: 33486571)
21. Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score.
Huynh-Le MP; Karunamuni R; Fan CC; Asona L; Thompson WK; Martinez ME; Eeles RA; Kote-Jarai Z; Muir KR; Lophatananon A; Schleutker J; Pashayan N; Batra J; Grönberg H; Neal DE; Nordestgaard BG; Tangen CM; MacInnis RJ; Wolk A; Albanes D; Haiman CA; Travis RC; Blot WJ; Stanford JL; Mucci LA; West CML; Nielsen SF; Kibel AS; Cussenot O; Berndt SI; Koutros S; Sørensen KD; Cybulski C; Grindedal EM; Menegaux F; Park JY; Ingles SA; Maier C; Hamilton RJ; Rosenstein BS; Lu YJ; Watya S; Vega A; Kogevinas M; Wiklund F; Penney KL; Huff CD; Teixeira MR; Multigner L; Leach RJ; Brenner H; John EM; Kaneva R; Logothetis CJ; Neuhausen SL; De Ruyck K; Ost P; Razack A; Newcomb LF; Fowke JH; Gamulin M; Abraham A; Claessens F; Castelao JE; Townsend PA; Crawford DC; Petrovics G; van Schaik RHN; Parent MÉ; Hu JJ; Zheng W; ; ; ; ; ; ; ; Mills IG; Andreassen OA; Dale AM; Seibert TM
Prostate Cancer Prostatic Dis; 2022 Apr; 25(4):755-761. PubMed ID: 35152271
[TBL] [Abstract][Full Text] [Related]
22. [Familial prostate cancer and genetic predisposition].
Meissner VH; Jahnen M; Herkommer K
Urologe A; 2021 May; 60(5):567-575. PubMed ID: 33721089
[TBL] [Abstract][Full Text] [Related]
23. Rare germline genetic variants and risk of aggressive prostate cancer.
Nguyen-Dumont T; MacInnis RJ; Steen JA; Theys D; Tsimiklis H; Hammet F; Mahmoodi M; Pope BJ; Park DJ; Mahmood K; Severi G; Bolton D; Milne RL; Giles GG; Southey MC
Int J Cancer; 2020 Oct; 147(8):2142-2149. PubMed ID: 32338768
[TBL] [Abstract][Full Text] [Related]
24. Replication study of 34 common SNPs associated with prostate cancer in the Romanian population.
Jinga V; Csiki IE; Manolescu A; Iordache P; Mates IN; Radavoi D; Rascu S; Badescu D; Badea P; Mates D
J Cell Mol Med; 2016 Apr; 20(4):594-600. PubMed ID: 26773531
[TBL] [Abstract][Full Text] [Related]
25. Hereditary prostate cancer: clinical aspects.
Bratt O
J Urol; 2002 Sep; 168(3):906-13. PubMed ID: 12187189
[TBL] [Abstract][Full Text] [Related]
26. A genome-wide association study of prostate cancer in Latinos.
Du Z; Hopp H; Ingles SA; Huff C; Sheng X; Weaver B; Stern M; Hoffmann TJ; John EM; Van Den Eeden SK; Strom S; Leach RJ; Thompson IM; Witte JS; Conti DV; Haiman CA
Int J Cancer; 2020 Apr; 146(7):1819-1826. PubMed ID: 31226226
[TBL] [Abstract][Full Text] [Related]
27. Men with a susceptibility to prostate cancer and the role of genetic based screening.
Eeles R; Ni Raghallaigh H
Transl Androl Urol; 2018 Feb; 7(1):61-69. PubMed ID: 29594021
[TBL] [Abstract][Full Text] [Related]
28. Initial outcomes and insights from a novel high-risk prostate cancer screening clinic.
Harper JB; Greenberg SE; Hunt TC; Cooney KA; O'Neil BB
Prostate; 2023 Feb; 83(2):151-157. PubMed ID: 36207779
[TBL] [Abstract][Full Text] [Related]
29. Prostate cancer screening using risk stratification based on a multi-state model of genetic variants.
Yen AM; Auvinen A; Schleutker J; Wu YY; Fann JC; Tammela T; Chen SL; Chiu SY; Chen HH
Prostate; 2015 Jun; 75(8):825-35. PubMed ID: 25683204
[TBL] [Abstract][Full Text] [Related]
30. Perspective: prostate cancer susceptibility genes.
Simard J; Dumont M; Soucy P; Labrie F
Endocrinology; 2002 Jun; 143(6):2029-40. PubMed ID: 12021166
[TBL] [Abstract][Full Text] [Related]
31. Translating genetic risk factors for prostate cancer to the clinic: 2013 and beyond.
Mikropoulos C; Goh C; Leongamornlert D; Kote-Jarai Z; Eeles R
Future Oncol; 2014; 10(9):1679-94. PubMed ID: 25145435
[TBL] [Abstract][Full Text] [Related]
32. The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer.
Maia S; Cardoso M; Paulo P; Pinheiro M; Pinto P; Santos C; Pinto C; Peixoto A; Henrique R; Teixeira MR
Fam Cancer; 2016 Jan; 15(1):111-21. PubMed ID: 26289772
[TBL] [Abstract][Full Text] [Related]
33. Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study.
Mitra AV; Bancroft EK; Barbachano Y; Page EC; Foster CS; Jameson C; Mitchell G; Lindeman GJ; Stapleton A; Suthers G; Evans DG; Cruger D; Blanco I; Mercer C; Kirk J; Maehle L; Hodgson S; Walker L; Izatt L; Douglas F; Tucker K; Dorkins H; Clowes V; Male A; Donaldson A; Brewer C; Doherty R; Bulman B; Osther PJ; Salinas M; Eccles D; Axcrona K; Jobson I; Newcombe B; Cybulski C; Rubinstein WS; Buys S; Townshend S; Friedman E; Domchek S; Ramon Y Cajal T; Spigelman A; Teo SH; Nicolai N; Aaronson N; Ardern-Jones A; Bangma C; Dearnaley D; Eyfjord J; Falconer A; Grönberg H; Hamdy F; Johannsson O; Khoo V; Kote-Jarai Z; Lilja H; Lubinski J; Melia J; Moynihan C; Peock S; Rennert G; Schröder F; Sibley P; Suri M; Wilson P; Bignon YJ; Strom S; Tischkowitz M; Liljegren A; Ilencikova D; Abele A; Kyriacou K; van Asperen C; Kiemeney L; ; Easton DF; Eeles RA
BJU Int; 2011 Jan; 107(1):28-39. PubMed ID: 20840664
[TBL] [Abstract][Full Text] [Related]
34. The role of genetic testing in prostate cancer screening, diagnosis, and treatment.
de la Calle CM; Bhanji Y; Pavlovich CP; Isaacs WB
Curr Opin Oncol; 2022 May; 34(3):212-218. PubMed ID: 35238838
[TBL] [Abstract][Full Text] [Related]
35. Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.
Wiklund F; Zheng SL; Sun J; Adami HO; Lilja H; Hsu FC; Stattin P; Adolfsson J; Cramer SD; Duggan D; Carpten JD; Chang BL; Isaacs WB; Grönberg H; Xu J
Prostate; 2009 Mar; 69(4):419-27. PubMed ID: 19116992
[TBL] [Abstract][Full Text] [Related]
36. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence.
Hayes JH; Barry MJ
JAMA; 2014 Mar; 311(11):1143-9. PubMed ID: 24643604
[TBL] [Abstract][Full Text] [Related]
37. Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen.
Vickers AJ; Sjoberg DD; Ulmert D; Vertosick E; Roobol MJ; Thompson I; Heijnsdijk EA; De Koning H; Atoria-Swartz C; Scardino PT; Lilja H
BMC Med; 2014 Feb; 12():26. PubMed ID: 24512643
[TBL] [Abstract][Full Text] [Related]
38. Family History of Prostate Cancer and Survival Outcomes in the UK Genetic Prostate Cancer Study.
Brook MN; Ní Raghallaigh H; Govindasami K; Dadaev T; Rageevakumar R; Keating D; Hussain N; Osborne A; Lophatananon A; ; Muir KR; Kote-Jarai Z; Eeles RA
Eur Urol; 2023 Mar; 83(3):257-266. PubMed ID: 36528478
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.
Klein RJ; Hallden C; Gupta A; Savage CJ; Dahlin A; Bjartell A; Manjer J; Scardino PT; Ulmert D; Wallström P; Vickers AJ; Lilja H
Eur Urol; 2012 Mar; 61(3):471-7. PubMed ID: 22101116
[TBL] [Abstract][Full Text] [Related]
40. Polygenic Risk Scores in Prostate Cancer Risk Assessment and Screening.
Byrne L; Toland AE
Urol Clin North Am; 2021 Aug; 48(3):387-399. PubMed ID: 34210493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
